Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Assessment of patient preferences among men with prostate cancer.

Albertsen PC, Nease RF Jr, Potosky AL.

J Urol. 1998 Jan;159(1):158-63.

PMID:
9400461
2.

The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure.

Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Brook RH.

Med Care. 1998 Jul;36(7):1002-12.

PMID:
9674618
3.

Patient and community preferences for outcomes in prostate cancer: implications for clinical policy.

Krahn M, Ritvo P, Irvine J, Tomlinson G, Bremner KE, Bezjak A, Trachtenberg J, Naglie G.

Med Care. 2003 Jan;41(1):153-64.

PMID:
12544552
5.

Health-related quality of life, satisfaction, and economic outcome measures in studies of prostate cancer screening and treatment, 1990-2000.

McNaughton-Collins M, Walker-Corkery E, Barry MJ.

J Natl Cancer Inst Monogr. 2004;(33):78-101. Review.

PMID:
15504921
6.

Patient preferences for outcomes associated with surgical management of prostate cancer.

Smith DS, Krygiel J, Nease RF Jr, Sumner W 2nd, Catalona WJ.

J Urol. 2002 May;167(5):2117-22.

PMID:
11956454
7.

Reliability and validity of the PORPUS, a combined psychometric and utility-based quality-of-life instrument for prostate cancer.

Ritvo P, Irvine J, Naglie G, Tomlinson G, Bezjak A, Matthew A, Trachtenberg J, Krahn M.

J Clin Epidemiol. 2005 May;58(5):466-74.

PMID:
15845333
8.

Predictors of utilities for health states in early stage prostate cancer.

Saigal CS, Gornbein J, Nease R, Litwin MS.

J Urol. 2001 Sep;166(3):942-6.

PMID:
11490251
9.

Measurement of health-related quality of life in men with prostate cancer: the CaPSURE database.

Lubeck DP, Litwin MS, Henning JM, Carroll PR.

Qual Life Res. 1997 Jul;6(5):385-92.

PMID:
9290305
10.

Utilities for prostate cancer health states in men aged 60 and older.

Stewart ST, Lenert L, Bhatnagar V, Kaplan RM.

Med Care. 2005 Apr;43(4):347-55.

PMID:
15778638
11.
12.

Quality of life in metastatic prostate cancer among men of lower socioeconomic status: feasibility and criterion related validity of 3 measures.

Knight SJ, Chmiel JS, Kuzel T, Sharp L, Albers M, Fine R, Moran EM, Nadler RB, Sharifi R, Bennett CL.

J Urol. 1998 Nov;160(5):1765-9.

PMID:
9783948
13.

Dimensions of quality of life expressed by men treated for metastatic prostate cancer.

Clark JA, Wray N, Brody B, Ashton C, Giesler B, Watkins H.

Soc Sci Med. 1997 Oct;45(8):1299-309.

PMID:
9381242
14.

Paper standard gamble: a paper-based measure of standard gamble utility for current health.

Ross PL, Littenberg B, Fearn P, Scardino PT, Karakiewicz PI, Kattan MW.

Int J Technol Assess Health Care. 2003 Winter;19(1):135-47.

PMID:
12701946
15.

Pilot study of a utilities-based treatment decision intervention for prostate cancer patients.

Knight SJ, Nathan DP, Siston AK, Kattan MW, Elstein AS, Collela KM, Wolf MS, Slimack NS, Bennett CL, Golub RM.

Clin Prostate Cancer. 2002 Sep;1(2):105-14.

PMID:
15046701
16.

Predictors of preferences and utilities in men treated with 3D-CRT for prostate cancer.

Bruner DW, Hanlon A, Mazzoni S, Raysor S, Konski A, Hanks G, Pollack A.

Int J Radiat Oncol Biol Phys. 2004 Jan 1;58(1):34-42.

PMID:
14697418
17.

Sociodemographic characteristics and health related quality of life in men attending prostate cancer support groups.

Katz D, Koppie TM, Wu D, Meng MV, Grossfeld GD, Sadesky N, Lubeck DP, Carroll PR.

J Urol. 2002 Nov;168(5):2092-6.

PMID:
12394716
19.

A review of measurement of patient preferences for treatment outcomes after prostate cancer.

Lubeck DP, Grossfeld GD, Carroll PR.

Urology. 2002 Sep;60(3 Suppl 1):72-7; discussion 77-8. Review.

PMID:
12231054
20.

Predictors of patient preferences and treatment choices for localized prostate cancer.

Sommers BD, Beard CJ, D'Amico AV, Kaplan I, Richie JP, Zeckhauser RJ.

Cancer. 2008 Oct 15;113(8):2058-67. doi: 10.1002/cncr.23807.

Supplemental Content

Support Center